Variant report
Variant | esv2547748 |
---|---|
Chromosome Location | chr2:76525879-76529668 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532617853 | chr2:76525915-76525916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs207461867 | chr2:76525982-76525983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190429726 | chr2:76526008-76526009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565945568 | chr2:76526028-76526029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536262085 | chr2:76526030-76526031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs115816095 | chr2:76526034-76526035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs569546384 | chr2:76526058-76526059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs180694979 | chr2:76526067-76526068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558351240 | chr2:76526073-76526074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574352522 | chr2:76526074-76526075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs35028300 | chr2:76526102-76526103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545167007 | chr2:76526111-76526112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs202024174 | chr2:76526115-76526116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201943410 | chr2:76526139-76526140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs70937901 | chr2:76526140-76526141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4853213 | chr2:76526142-76526143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372529090 | chr2:76526143-76526144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs77021092 | chr2:76526144-76526145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201609451 | chr2:76526170-76526171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375898338 | chr2:76526182-76526183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186048130 | chr2:76526183-76526184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561381446 | chr2:76526200-76526201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531598583 | chr2:76526201-76526202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191298704 | chr2:76526220-76526221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565213201 | chr2:76526231-76526232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532361357 | chr2:76526235-76526236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs13005979 | chr2:76526252-76526253 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs181211542 | chr2:76526258-76526259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185800298 | chr2:76526300-76526301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190612758 | chr2:76526306-76526307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs13006506 | chr2:76526320-76526321 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs569664025 | chr2:76526371-76526372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377233241 | chr2:76526378-76526379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs66608266 | chr2:76526379-76526380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs75623668 | chr2:76526390-76526391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201027776 | chr2:76526392-76526393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567327899 | chr2:76526435-76526436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183171203 | chr2:76526439-76526440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs201739246 | chr2:76526513-76526514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371326871 | chr2:76527146-76527147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs376046948 | chr2:76527213-76527214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368596950 | chr2:76527237-76527238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs371523566 | chr2:76527246-76527247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs376614704 | chr2:76527441-76527442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372463949 | chr2:76527443-76527444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375816171 | chr2:76527444-76527445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs367875889 | chr2:76527668-76527669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539005511 | chr2:76527675-76527676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371710322 | chr2:76527741-76527742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs376290466 | chr2:76527774-76527775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:76524800-76526000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr2:76525000-76526000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr2:76525200-76526200 | Enhancers | Fetal Lung | lung |
4 | chr2:76525400-76526200 | Enhancers | Fetal Heart | heart |
5 | chr2:76525400-76526400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr2:76525600-76526000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr2:76526000-76526400 | Enhancers | Fetal Brain Male | brain |
8 | chr2:76526400-76532400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |